Cytokine PharmaSciences announced the completion of its Phase 2 study of the misoprostol vaginal insert (MVI) for cervical ripening and induction of labor. This randomized, double-blind, multi-center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results